BusinessAlvogen CEO Robert Wessman speaks exclusively to World Finance about new opportunities in generic pharmaceuticalsBy Nasdaq OMXJan 22, 2018, 10:04 AM UTC
BusinessA man on a mission to transform generic pharmaceuticals: Alvogen CEO and founder, Robert Wessman, discusses the company’s growthBy Nasdaq OMXJan 4, 2018, 11:16 AM UTC
BusinessSignet Healthcare Partners Closes $137.2 Million Life Science FundBy Nasdaq OMXJan 11, 2017, 10:53 PM UTC
